$14.50
0.10.69%
Pre-Market: Jul 19, 7:16 PM EDT
15 minutes delayed
Comments
Loading...
4D Molecular Therapeutics
FDMTNASDAQ
4D Molecular Therapeutics (FDMT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest4D Molecular Therapeutics (NASDAQ:FDMT) Stock Quotes, Forecast and News Summary
4D Molecular Therapeutics Stock (NASDAQ: FDMT) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 88.00 / 741.22K |
| Day Range | - - - |
| 52 Wk Range | 9.44 - 36.25 |
| Market Cap | $749.70M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 28 |
| Short Interest | 19.82% |
| Days to Cover | 10.88 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About 4D Molecular Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy 4D Molecular Therapeutics (FDMT) stock?
You can purchase shares of 4D Molecular Therapeutics (NASDAQ:FDMT) through any online brokerage.
Who are 4D Molecular Therapeutics (FDMT) competitors?
Other companies in 4D Molecular Therapeutics’s space includes: Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB), Sage Therapeutics (NASDAQ:SAGE) and AnaptysBio (NASDAQ:ANAB).
What is the target price for 4D Molecular Therapeutics (FDMT) stock?
There is no analysis for 4D Molecular Therapeutics.
What is the forecast for 4D Molecular Therapeutics (FDMT) stock?
4D Molecular Therapeutics has a consensus price target of $39.09.
Current stock price for 4D Molecular Therapeutics (FDMT)?
The stock price for 4D Molecular Therapeutics (NASDAQ: FDMT) is $14.5 last updated July 19, 2024 at 7:16 PM EDT.
Does 4D Molecular Therapeutics (FDMT) pay a dividend?
There are no upcoming dividends for 4D Molecular Therapeutics.
When is 4D Molecular Therapeutics (NASDAQ:FDMT) reporting earnings?
4D Molecular Therapeutics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is 4D Molecular Therapeutics (FDMT) going to split?
There is no upcoming split for 4D Molecular Therapeutics.
What sector and industry does 4D Molecular Therapeutics (FDMT) operate in?
4D Molecular Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.